feed,title,long_url,short_url
Benzinga,"Surging Omicron-Related Cases Lift LumiraDx Q4 Sales, Expects Sequentially Flat Q1 FY22 Sales",https://benzinga.com/news/earnings/22/03/26078357/surging-omicron-related-cases-lift-lumiradx-q4-sales-expects-sequentially-flat-q1-fy22-sales,https://bit.ly/35Fws6R
